Anagha Jagannathan, Carlos Real Jiménez, Laura Cádiz, Sofía Trigo Anca, Anabel Díaz-Guerra Priego, Miguel Fernández Tocino, Carlos Galán Arriola, Borja Ibáñez, Agustín Clemente Moragón, Sandra Gomez, Ana Devesa, Juan Rene Delgado Cornejo, Danielle Medina-Hernandez, Warren Alexander Skoza, Lucía Pilar López Palomar, Nico Hoffmann, Carlos Caballero Henares and Ángela Pollán García.
    Research, Publications
    JACC CardioOncology: CNIC scientists design an effective treatment strategy to prevent heart injury caused by a class of anticancer drugs

    The study, published in JACC: CardioOncology, shows that administration of the SGLT2 inhibitor empagliflozin to pigs receiving anthracyclines preserves mitochondrial function, improves myocardial energetics, and prevents degenerative changes in heart structure

    Ana Botín and Valentín Fuster
    About the CNIC, Research
    The PESA CNIC-Santander study consolidates itself as the most important study in the world in the diagnosis and prevention of cardiovascular diseases

    The findings of this study have been key for the development of REACT, a new research project, that will count on the collaboration of Santander Bank, and will expand the study of the age group for the prevention of cardiovascular diseases, which will include 8,000 new participants.

    imagen
    About the CNIC
    European Researchers’ Night 2024 at CNIC
    Vicente Andrés, Borja Ibáñez, Valentín Fuster, Ana García Álvarez, José Javier Fuster, Inés García Lunar, Antonio Quesada y Virginia Mass Ruiz.
    Research, Publications
    JACC: Progression of subclinical atherosclerosis predicts all-cause mortality risk

    A study published in The Journal of the American College of Cardiology (JACC) demonstrates that the burden and progression of silent atherosclerosis in

    •  
    • 1 of 7